Connect your AI client via MCP

Endpoint (paste into an MCP client — anonymous, free, no key)

https://mcp.koalcheck.com/mcp

Or copy this and send it to your AI to set it up:

Add the "koalcheck" MCP server to my client and connect. It is a remote Streamable-HTTP server at https://mcp.koalcheck.com/mcp — connect anonymously, no API key or login needed (the free tools work right away). If my client supports a remote/HTTP MCP server directly, just use that URL. If my client config only accepts a local command (e.g. Claude Desktop's mcpServers, which rejects a bare "url"), bridge it with command "npx" and args ["-y","mcp-remote","https://mcp.koalcheck.com/mcp"]. Then tell me to fully restart the client, and list the koalcheck tools you can call. It provides US-equity research tools built on an analyst track-record engine (who has actually been right, priced vs SPY, cross-checked with SEC & FINRA).

Capabilities User guide

← @jam_croissant

$SLNO

BULLISH2026-03-31

Price around the call

↑ 2026-03-31

By horizon✓ hit+32.9%

✓ +6.7%

✓ +38.2%

21d

✓ +32.9%

Original post

Cem Karsan 🥐 · 2026-03-31

🥐RUMBS 👇 With $APLS being taken out overnight for a $ñ150% premium… Soleno Therapeutics $SLNO should be next… They’ve already penetrated >1.25k of the 10k patients in the US & should 2x that in the next year… That would be $6-8/share in FCF!! And W/ $500 mil in 💰, that’san enterprise value of only $23/share. The ultimate annual opportunity is 5k-7k patients 👇. & the ONLY competitor was a competing drug from Aardvark [$AARD] which was halted for safety…leaving $SLNO as the ONLY 💊 option. It’s just a ❓ of how quickly theyre going to ramp to $16/share in FCF. It may be the cheapest stock in the whole market w/ M&A in the sector 🔥 up… (*Not investment advice- Donyour own research…I own the stock 🤑)

View on X ↗